The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60. Health ...

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

The ACIP is recommending the use of Enflonsia for the prevention of RSV lower respiratory tract disease in infants younger than 8 months.

Fact checked by Jennifer Klump A group of advisors to the Centers for Disease Control and Prevention (CDC) voted 5-2 to ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

A medical panel appointed by Health Secretary Robert F. Kennedy Jr. voted Thursday to recommend a new preventive shot against ...

The CDC's newly reconstituted Advisory Committee on Immunization Practices (ACIP) voted 5-2 in support of infants younger ...

It has proved that the auscultation of respiratory sound has advantage in early respiratory diagnosis. Various methods have been raised to perform automatic respiratory sound analysis to reduce ...

The University of OklahomaAs a student, it’s important that you be aware of the recent increase in COVID positivity rates and hospitalizations in the state. To help keep all respiratory virus ...

Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory infections for which effective treatment options remain limited. Herein, we employed a computational structure-based ...

Bibasilar crackles are atypical sounds from the base of the lungs, and they usually signal a problem with airflow. Learn the causes, treatments, and more.

Nirsevimab offers consistent and sustained protection against hospitalisation due to RSV-associated lower respiratory tract infection for at least 6 months. This finding provides global health systems ...